Showing results (1151-1160 of 1,217) with videos related to

Sort By:
Pageof 122
Journal of Neurodevelopmental Disorders|July 26, 2023
Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS)Jorrit Tjeertes, Carlos A Bacino, Terry Jo Bichell, et al.
Lancet (London, England)|April 13, 2011
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trialPaul D Griffiths, Anna Stanton, Erin McCarrell, et al.
Plos One|November 27, 2013
A broad phenotypic screen identifies novel phenotypes driven by a single mutant allele in Huntington's disease CAG knock-in miceSabine M Hölter, Mary Stromberg, Marina Kovalenko, et al.
Circulation|February 8, 2021
Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE TrialNan Ye, Meg J Jardine, Megumi Oshima, et al.
Science Advances|July 8, 2016
Synergistic roles of climate warming and human occupation in Patagonian megafaunal extinctions during the Last DeglaciationJessica L Metcalf, Chris Turney, Ross Barnett, et al.
BMC Nephrology|July 27, 2022
The effect of intravenous iron supplementation on exercise capacity in iron-deficient but not anaemic patients with chronic kidney disease: study design and baseline data for a multicentre prospective double-blind randomised controlled trialSharlene A Greenwood, Nicholas Beckley-Hoelscher, Elham Asgari, et al.
American Journal of Nephrology|November 3, 2021
The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline CharacteristicsMuh Geot Wong, Jicheng Lv, Michelle A Hladunewich, et al.
Kidney International Reports|June 2, 2018
Risk Factors for Prognosis in Patients With Severely Decreased GFRMarie Evans, Morgan E Grams, Yingying Sang, et al.
Trials|August 14, 2016
Standardised Outcomes in Nephrology-Children and Adolescents (SONG-Kids): a protocol for establishing a core outcome set for children with chronic kidney diseaseAllison Tong, Susan Samuel, Michael Zappitelli, et al.
Human Molecular Genetics|August 8, 2020
Patterns of CAG repeat instability in the central nervous system and periphery in Huntington's disease and in spinocerebellar ataxia type 1Ricardo Mouro Pinto, Larissa Arning, James V Giordano, et al.
Pageof 122